Content Library

Evaluating the safety of a self-amplifying mRNA vaccine in rats

What is self-amplifying mRNA technology? Self-amplifying mRNA (SAM) technology is a relatively novel approach in vaccinology. It consists of an engineered replication-deficient alphavirus genome encoding an RNA-dependent RNA polymerase and the gene of the target antigen. The benefit that SAM technology holds over conventional vaccinology is its potential for the rapid development and large-scale production of a vaccine in the event of an unpredictable epidemic outbreak.

Upcoming Events

European Congress of Toxicologic Pathology

Date: Sept. 26-29, 2023
Location: Basel, Switzerland
We're attending - connect with our team!

ESGCT 30th Annual Congress

Date: Oct. 24-27, 2023
Location: Brussels, Belgium
Stop by our Booth #52 and connect with our team!

ACVP/ASCVP Annual Meeting

Date: Oct. 28-31, 2023
Location: Chicago, Illinois

Learn more about StageBio’s COVID-19 response